|
|
|
|
Our 3 cases highlight the occurrence of myoclonus during the COVID-19 pandemic as a post-or para-infectious immune-mediated disorder. However, we cannot rule out that SARS-CoV-2 may spread transneuronally to first- and second-order structures connected with the olfactory bulb. Further investigation is required to clarify the full clinical spectrum of neurologic symptoms and optimal treatment. |
|